{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:01:19Z","timestamp":1775041279272,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"AHA Heart Failure Strategically Focused Research Network"},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017995","name":"Nora Eccles Treadwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10621-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:46:28Z","timestamp":1775029588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["International Utah Cardiac Recovery Symposium (U-CARS) 2025: Clinical Science Proceedings"],"prefix":"10.1007","volume":"31","author":[{"given":"Ioannis","family":"Kyriakoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manreet K.","family":"Kanwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig H.","family":"Selzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros G.","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"3","key":"10621_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ehf2.12629","volume":"7","author":"CFJ Antonides","year":"2020","unstructured":"Antonides CFJ et al (2020) Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study. ESC Heart Fail 7(3):1085\u20131094","journal-title":"ESC Heart Fail"},{"issue":"14","key":"10621_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jacc.2016.07.743","volume":"68","author":"O Wever-Pinzon","year":"2016","unstructured":"Wever-Pinzon O et al (2016) Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. J Am Coll Cardiol 68(14):1540\u20131553","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10621_CR3","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.120.046415","volume":"142","author":"EJ Birks","year":"2020","unstructured":"Birks EJ et al (2020) Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation 142(21):2016\u20132028","journal-title":"Circulation"},{"issue":"18","key":"10621_CR4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1056\/NEJMoa053063","volume":"355","author":"EJ Birks","year":"2006","unstructured":"Birks EJ et al (2006) Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355(18):1873\u20131884","journal-title":"N Engl J Med"},{"issue":"4","key":"10621_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","volume":"123","author":"EJ Birks","year":"2011","unstructured":"Birks EJ et al (2011) Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 123(4):381\u2013390","journal-title":"Circulation"},{"issue":"4","key":"10621_CR6","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.healun.2024.02.168","volume":"43","author":"E Maneta","year":"2024","unstructured":"Maneta E et al (2024) Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling. J Heart Lung Transplantation 43(4):S83","journal-title":"J Heart Lung Transplantation"},{"issue":"15","key":"10621_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","volume":"378","author":"MR Mehra","year":"2018","unstructured":"Mehra MR et al (2018) Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med 378(15):1386\u20131395","journal-title":"N Engl J Med"},{"issue":"19","key":"10621_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.jacc.2013.01.072","volume":"61","author":"SG Drakos","year":"2013","unstructured":"Drakos SG et al (2013) Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol 61(19):1985\u20131994","journal-title":"J Am Coll Cardiol"},{"key":"10621_CR9","doi-asserted-by":"crossref","unstructured":"Nickel I et al (2025) (7) - Left Ventricular Assist Device Explant versus Decommissioning: A VAD Wean Registry Analysis. The Journal of Heart and Lung Transplantation, 44(4, Supplement): pp. S4-S5","DOI":"10.1016\/j.healun.2025.02.012"},{"issue":"7","key":"10621_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.12.004","volume":"42","author":"D Saeed","year":"2023","unstructured":"Saeed D et al (2023) The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update. J Heart Lung Transpl 42(7):e1\u2013e222","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"10621_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.healun.2022.05.015","volume":"41","author":"MK Kanwar","year":"2022","unstructured":"Kanwar MK et al (2022) Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support. J Heart Lung Transpl 41(10):1324\u20131334","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10621_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ejhf.1018","volume":"20","author":"AB Catino","year":"2018","unstructured":"Catino AB et al (2018) Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support. Eur J Heart Fail 20(1):164\u2013174","journal-title":"Eur J Heart Fail"},{"key":"10621_CR13","doi-asserted-by":"crossref","unstructured":"Topkara VK et al (2016) Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Circ Heart Fail, 9(7):e003157","DOI":"10.1161\/CIRCHEARTFAILURE.116.003157"},{"issue":"1","key":"10621_CR14","doi-asserted-by":"publisher","first-page":"e008711","DOI":"10.1161\/CIRCHEARTFAILURE.121.008711","volume":"15","author":"VK Topkara","year":"2022","unstructured":"Topkara VK et al (2022) Machine Learning-Based Prediction of Myocardial Recovery in Patients With Left Ventricular Assist Device Support. Circ Heart Fail 15(1):e008711","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10621_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jchf.2023.12.006","volume":"12","author":"S Itagaki","year":"2024","unstructured":"Itagaki S et al (2024) Incidence, Outcomes, and Opportunity for Left Ventricular Assist Device Weaning for Myocardial Recovery. JACC Heart Fail 12(5):893\u2013901","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10621_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jacc.2021.12.022","volume":"79","author":"VK Topkara","year":"2022","unstructured":"Topkara VK et al (2022) Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. J Am Coll Cardiol 79(9):900\u2013913","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10621_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/eurjhf\/hft094","volume":"15","author":"KM Swetz","year":"2013","unstructured":"Swetz KM et al (2013) Clinicians\u2019 attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of life. Eur J Heart Fail 15(11):1262\u20131266","journal-title":"Eur J Heart Fail"},{"key":"10621_CR18","doi-asserted-by":"crossref","unstructured":"Brugts JJ et al (2021) Clinical Update of the Latest Evidence for CardioMEMS Pulmonary Artery Pressure Monitoring in Patients with Chronic Heart Failure: A Promising System for Remote Heart Failure Care. Sens (Basel), 21(7):2335","DOI":"10.3390\/s21072335"},{"key":"10621_CR19","unstructured":"https:\/\/unos.my.salesforce.com\/sfc\/p\/#80000000bHuz\/a\/RP000006fj49\/XrmDY8HhbJpWdvpKZjoxk1CilG3oYB74TyWrS1WnwaY"},{"issue":"5","key":"10621_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/ALN.0000000000005336","volume":"142","author":"M Baiardo Redaelli","year":"2025","unstructured":"Baiardo Redaelli M et al (2025) Amino Acid Infusion for Kidney Protection in Cardiac Surgery Patients with Chronic Kidney Disease: A Secondary Analysis of the PROTECTION Trial. Anesthesiology 142(5):818\u2013828","journal-title":"Anesthesiology"},{"key":"10621_CR21","doi-asserted-by":"crossref","unstructured":"Belletti A et al (2025) Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study. Eur J Cardiothorac Surg, 67(2):ezaf035","DOI":"10.1093\/ejcts\/ezaf035"},{"issue":"10","key":"10621_CR22","first-page":"651","volume":"12","author":"DD Berg","year":"2023","unstructured":"Berg DD et al (2023) Prognostic significance of haemodynamic parameters in patients with cardiogenic shock. Eur Heart J Acute Cardiovasc Care 12(10):651\u2013660","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"10621_CR23","doi-asserted-by":"publisher","first-page":"e011827","DOI":"10.1161\/CIRCHEARTFAILURE.124.011827","volume":"17","author":"MA Chavez","year":"2024","unstructured":"Chavez MA et al (2024) Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circ Heart Fail 17(9):e011827","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10621_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.123.21913","volume":"81","author":"A Picod","year":"2024","unstructured":"Picod A et al (2024) Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides. Hypertension 81(4):927\u2013935","journal-title":"Hypertension"},{"issue":"5","key":"10621_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A et al (2017) Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med 377(5):419\u2013430","journal-title":"N Engl J Med"},{"issue":"8","key":"10621_CR26","first-page":"1286","volume":"38","author":"BN Tehrani","year":"2022","unstructured":"Tehrani BN et al (2022) The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design. Can J Cardiol 38(8):1286\u20131295","journal-title":"Can J Cardiol"},{"issue":"2","key":"10621_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2112299","volume":"386","author":"WF Fearon","year":"2022","unstructured":"Fearon WF et al (2022) Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. N Engl J Med 386(2):128\u2013137","journal-title":"N Engl J Med"},{"issue":"10","key":"10621_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961\u2013972","journal-title":"N Engl J Med"},{"issue":"10206","key":"10621_CR29","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","volume":"394","author":"D Thuijs","year":"2019","unstructured":"Thuijs D et al (2019) Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet 394(10206):1325\u20131334","journal-title":"Lancet"},{"issue":"25","key":"10621_CR30","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh ME et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367(25):2375\u20132384","journal-title":"N Engl J Med"},{"issue":"20","key":"10621_CR31","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1161\/CIRCULATIONAHA.106.612267","volume":"113","author":"EL Hannan","year":"2006","unstructured":"Hannan EL et al (2006) Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113(20):2406\u20132412","journal-title":"Circulation"},{"issue":"8","key":"10621_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJM198808253190802","volume":"319","author":"TF Luscher","year":"1988","unstructured":"Luscher TF et al (1988) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319(8):462\u2013467","journal-title":"N Engl J Med"},{"issue":"17","key":"10621_CR33","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","volume":"364","author":"EJ Velazquez","year":"2011","unstructured":"Velazquez EJ et al (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607\u20131616","journal-title":"N Engl J Med"},{"issue":"6","key":"10621_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamacardio.2020.0239","volume":"5","author":"LY Sun","year":"2020","unstructured":"Sun LY et al (2020) Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting. JAMA Cardiol 5(6):631\u2013641","journal-title":"JAMA Cardiol"},{"issue":"15","key":"10621_CR35","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","volume":"387","author":"D Perera","year":"2022","unstructured":"Perera D et al (2022) Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N Engl J Med 387(15):1351\u20131360","journal-title":"N Engl J Med"},{"issue":"13","key":"10621_CR36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/2047487319835042","volume":"26","author":"JF Veenis","year":"2019","unstructured":"Veenis JF et al (2019) Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol 26(13):1399\u20131407","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10621_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ et al (2018) Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. J Am Coll Cardiol 72(4):351\u2013366","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10621_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","volume":"11","author":"G Savarese","year":"2023","unstructured":"Savarese G et al (2023) Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail 11(1):1\u201314","journal-title":"JACC Heart Fail"},{"issue":"10367","key":"10621_CR39","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A et al (2022) Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400(10367):1938\u20131952","journal-title":"Lancet"},{"issue":"5","key":"10621_CR40","first-page":"e35","volume":"143","author":"CM Otto","year":"2020","unstructured":"Otto CM et al (2020) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e35\u2013e71","journal-title":"Circulation"},{"issue":"15","key":"10621_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364(15):1395\u20131406","journal-title":"N Engl J Med"},{"issue":"24","key":"10621_CR42","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW et al (2018) Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 379(24):2307\u20132318","journal-title":"N Engl J Med"},{"issue":"19","key":"10621_CR43","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2408739","volume":"391","author":"S Baldus","year":"2024","unstructured":"Baldus S et al (2024) Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation. N Engl J Med 391(19):1787\u20131798","journal-title":"N Engl J Med"},{"issue":"5","key":"10621_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.21037\/atm-24-39","volume":"12","author":"F Nappi","year":"2024","unstructured":"Nappi F (2024) Comparing surgical techniques and results of secondary ischemic mitral regurgitation: a state-of-the-art literature review. Ann Transl Med 12(5):91","journal-title":"Ann Transl Med"},{"issue":"4","key":"10621_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJMoa1512913","volume":"374","author":"D Goldstein","year":"2016","unstructured":"Goldstein D et al (2016) Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med 374(4):344\u2013353","journal-title":"N Engl J Med"},{"issue":"3","key":"10621_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.optechstcvs.2012.04.003","volume":"17","author":"TE David","year":"2012","unstructured":"David TE (2012) Ischemic Mitral Regurgitation: Chordal-Sparing Mitral Valve Replacement. Operative Techniques Thorac Cardiovasc Surg 17(3):194\u2013203","journal-title":"Operative Techniques Thorac Cardiovasc Surg"},{"key":"10621_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.xjon.2024.07.021","volume":"22","author":"Z Dietze","year":"2024","unstructured":"Dietze Z et al (2024) Mitral valve replacement versus repair for severe mitral regurgitation in patients with reduced left ventricular ejection fraction. JTCVS Open 22:191\u2013207","journal-title":"JTCVS Open"},{"issue":"5","key":"10621_CR48","doi-asserted-by":"publisher","first-page":"958","DOI":"10.21037\/cdt-24-6","volume":"14","author":"SR Eapen","year":"2024","unstructured":"Eapen SR et al (2024) Secondary mitral regurgitation surgical management: a narrative review. Cardiovasc Diagn Ther 14(5):958\u2013973","journal-title":"Cardiovasc Diagn Ther"},{"key":"10621_CR49","doi-asserted-by":"crossref","unstructured":"Camaj A et al (2023) Heart Failure and Secondary Mitral Regurgitation: A Contemporary Review. J Soc Cardiovasc Angiogr Interv, 2023;2(6 Part B):101195","DOI":"10.1016\/j.jscai.2023.101195"},{"issue":"4","key":"10621_CR50","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/ehf2.12741","volume":"7","author":"T Gyoten","year":"2020","unstructured":"Gyoten T et al (2020) Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction. ESC Heart Fail 7(4):1781\u20131790","journal-title":"ESC Heart Fail"},{"issue":"12","key":"10621_CR51","doi-asserted-by":"publisher","first-page":"e0243737","DOI":"10.1371\/journal.pone.0243737","volume":"15","author":"MK Eickhoff","year":"2020","unstructured":"Eickhoff MK et al (2020) Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions. PLoS ONE 15(12):e0243737","journal-title":"PLoS ONE"},{"issue":"4","key":"10621_CR52","doi-asserted-by":"publisher","first-page":"S392","DOI":"10.1016\/j.healun.2024.02.1269","volume":"43","author":"J Baranowska","year":"2024","unstructured":"Baranowska J et al (2024) Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls. J Heart Lung Transplantation 43(4):S392","journal-title":"J Heart Lung Transplantation"},{"issue":"25","key":"10621_CR53","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/eurheartj\/ehac188","volume":"43","author":"E Braunwald","year":"2022","unstructured":"Braunwald E (2022) Cardiac cell therapy: a call for action. Eur Heart J 43(25):2352\u20132353","journal-title":"Eur Heart J"},{"issue":"9","key":"10621_CR54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","volume":"81","author":"EC Perin","year":"2023","unstructured":"Perin EC et al (2023) Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure. J Am Coll Cardiol 81(9):849\u2013863","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10621_CR55","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ejhf.2596","volume":"24","author":"B Vrtovec","year":"2022","unstructured":"Vrtovec B et al (2022) A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction. Eur J Heart Fail 24(8):1441\u20131449","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10621_CR56","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/j.healun.2024.02.1115","volume":"43","author":"B Vrtovec","year":"2024","unstructured":"Vrtovec B et al (2024) LVAD\/Stem Cell Combination Therapy in Nonischemic Dilated Cardiomyopathy Patients: Proof-of-Concept Study. J Heart Lung Transplantation 43(4):S234\u2013S235","journal-title":"J Heart Lung Transplantation"},{"issue":"3","key":"10621_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1067\/mtc.2003.28","volume":"125","author":"BP Leeuwenburgh","year":"2003","unstructured":"Leeuwenburgh BP et al (2003) Effects of acute left ventricular unloading on right ventricular function in normal and chronic right ventricular pressure-overloaded lambs. J Thorac Cardiovasc Surg 125(3):481\u2013490","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10621_CR58","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.healun.2017.03.014","volume":"36","author":"BA Houston","year":"2017","unstructured":"Houston BA et al (2017) A new twist on right heart failure with left ventricular assist systems. J Heart Lung Transpl 36(7):701\u2013707","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"10621_CR59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.healun.2023.11.015","volume":"43","author":"PJ Scheel III","year":"2024","unstructured":"Scheel PJ III et al (2024) Occult right ventricular dysfunction and right ventricular-vascular uncoupling in left ventricular assist device recipients. J Heart Lung Transpl 43(4):594\u2013603","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10621_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cardfail.2021.07.012","volume":"28","author":"S Hsu","year":"2022","unstructured":"Hsu S, Fang JC, Borlaug BA (2022) Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review. J Card Fail 28(1):133\u2013148","journal-title":"J Card Fail"},{"issue":"Suppl W","key":"10621_CR61","doi-asserted-by":"publisher","first-page":"pW60","DOI":"10.4244\/EIJV11SWA16","volume":"11","author":"RP Gooley","year":"2015","unstructured":"Gooley RP, Meredith IT (2015) The Accucinch transcatheter direct mitral valve annuloplasty system. EuroIntervention 11(Suppl W):pW60\u2013pW61","journal-title":"EuroIntervention"},{"issue":"7","key":"10621_CR62","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cardfail.2023.03.003","volume":"29","author":"N Hamid","year":"2023","unstructured":"Hamid N et al (2023) Transcatheter Left Ventricular Restoration in Patients With Heart Failure. J Card Fail 29(7):1046\u20131055","journal-title":"J Card Fail"},{"key":"10621_CR63","unstructured":"NCT (2020) 04331769, Randomized Clinical Evaluation of the AccuCinch\u00ae Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study"},{"issue":"1","key":"10621_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.healun.2022.08.030","volume":"42","author":"H Copeland","year":"2023","unstructured":"Copeland H et al (2023) Donor heart selection: Evidence-based guidelines for providers. J Heart Lung Transpl 42(1):7\u201329","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"10621_CR65","doi-asserted-by":"publisher","first-page":"e011360","DOI":"10.1161\/CIRCHEARTFAILURE.123.011360","volume":"17","author":"B Wayda","year":"2024","unstructured":"Wayda B et al (2024) Prediction of Donor Heart Acceptance for Transplant and Its Clinical Implications: Results From The Donor Heart Study. Circ Heart Fail 17(10):e011360","journal-title":"Circ Heart Fail"},{"key":"10621_CR66","unstructured":"Tool to Predict Heart Acceptance for Transplant [ToP-HAT], available at https:\/\/qsushiny.shinyapps.io\/TOPHAT\/ , as of May (2025)"},{"issue":"9","key":"10621_CR67","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1111\/febs.16429","volume":"290","author":"G Malovan","year":"2023","unstructured":"Malovan G et al (2023) The emerging role of dipeptidyl peptidase 3 in pathophysiology. FEBS J 290(9):2246\u20132262","journal-title":"FEBS J"},{"issue":"2","key":"10621_CR68","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ejhf.1601","volume":"22","author":"B Deniau","year":"2020","unstructured":"Deniau B et al (2020) Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics. Eur J Heart Fail 22(2):290\u2013299","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10621_CR69","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ejhf.1600","volume":"22","author":"K Takagi","year":"2020","unstructured":"Takagi K et al (2020) Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial. Eur J Heart Fail 22(2):279\u2013286","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10621_CR70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40635-024-00638-3","volume":"12","author":"B Garcia","year":"2024","unstructured":"Garcia B et al (2024) Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. Intensive Care Med Exp 12(1):53","journal-title":"Intensive Care Med Exp"},{"key":"10621_CR71","unstructured":"Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics\/-Dynamics of AK1967 (Procizumab). Accessed on May 2025 https:\/\/ctv.veeva.com\/study\/phase-1-study-to-evaluate-safety-tolerability-and-pharmacokinetics-dynamics-of-ak1967-"},{"key":"10621_CR72","unstructured":"Procizumab (PCZ; AK1967) in Critical Cardiovascular Care (PROCARD 1b). Accessed on May 2025 https:\/\/ctv.veeva.com\/study\/procizumab-pcz-ak1967-in-critical-cardiovascular-care?utm_source=chatgpt.com"},{"issue":"17","key":"10621_CR73","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10621_CR74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cjco.2020.03.009","volume":"2","author":"F Lee","year":"2020","unstructured":"Lee F et al (2020) Multidisciplinary Code Shock Team in Cardiogenic Shock: A Canadian Centre Experience. CJC Open 2(4):249\u2013257","journal-title":"CJC Open"},{"issue":"1","key":"10621_CR75","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.119.040654","volume":"140","author":"I Taleb","year":"2019","unstructured":"Taleb I et al (2019) Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. Circulation 140(1):98\u2013100","journal-title":"Circulation"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10621-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:07:50Z","timestamp":1775034470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10621"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10621-7","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding: AHA Heart Failure Strategically Focused Research Network, 16SFRN29020000 (Drs. Drakos, Stehlik and Selzman), 2. NHLBI R01 HL135121-01 (Dr. Drakos), 3. NHLBI R01 HL132067-01A1 (Dr. Drakos), 4. Nora Eccles Treadwell Foundation (Dr. Drakos), 5. Merit Review Award I01 CX002291 U.S. Department of Veterans Affairs (Dr. Drakos).Disclosures: Dr. Drakos serves as a consultant for Abbott and Berlin Heals and has received research support from Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr. Drakos serves as a consultant for Abbott and Berlin Heals and has received research support from Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics declaration"}}],"article-number":"51"}}